Elpen Pharmaceutical competitive analysis

Latest publications and patents of Elpen Pharmaceutical New

Explore the latest publications and patents granted to Elpen Pharmaceutical, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Elpen Pharmaceutical against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 21, 2025
New UseNOVARTISJul 11, 2024
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISOct 20, 2022

Latest PTAB cases involving Elpen Pharmaceutical

Discover the latest PTAB cases involving Elpen Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Elpen Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ELPEN PHARMACEUTICAL3 - - - Highly Aggressive
NOVARTIS6406 - 21Defensive